131 related articles for article (PubMed ID: 1590209)
1. Reimbursement for cognitive services: Quebec's experience.
Poirier S
Am Pharm; 1992 May; NS32(5):56-60. PubMed ID: 1590209
[No Abstract] [Full Text] [Related]
2. Introduction. Update on pharmaceutical reimbursement and implications for health-system pharmacists .
Johnson PE
Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S2-3. PubMed ID: 18192244
[No Abstract] [Full Text] [Related]
3. Reimbursement for clinical services.
Patel N; Murdico AT
Am J Health Syst Pharm; 2007 May; 64(9):926. PubMed ID: 17468146
[No Abstract] [Full Text] [Related]
4. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
Nutescu EA; Klotz RS
Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
[TBL] [Abstract][Full Text] [Related]
5. The challenge of Medicare Part D for community pharmacies.
Stone D
J Manag Care Pharm; 2009 Mar; 15(2):171-2. PubMed ID: 19236134
[No Abstract] [Full Text] [Related]
6. Billing for Medicare Part D vaccines.
Moore KJ
Fam Pract Manag; 2007; 14(7):33-4. PubMed ID: 17696056
[No Abstract] [Full Text] [Related]
7. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
Cirn JT
Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
[TBL] [Abstract][Full Text] [Related]
8. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
[TBL] [Abstract][Full Text] [Related]
9. Don't exclude community pharmacists.
Hoey BD
Mod Healthc; 2014 Mar; 44(10):26. PubMed ID: 24830277
[No Abstract] [Full Text] [Related]
10. Pharmacists praise new Medicare billing opportunities: provider status still critical, they say.
Traynor K
Am J Health Syst Pharm; 2015 Jan; 72(2):91-2. PubMed ID: 25550129
[No Abstract] [Full Text] [Related]
11. Bonanza for drug companies. Quebec's public drug plan pays for biotechnology boom.
Blair L
Can Fam Physician; 2002 Apr; 48():831, 833, 836-8. PubMed ID: 12046376
[No Abstract] [Full Text] [Related]
12. Capitation reimbursement for pharmacy services: a dissenting view.
Gosselin RA
Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
[No Abstract] [Full Text] [Related]
13. Capitation payment for pharmacy services: are we ready?
Berger BA
Med Mark Media; 1980 Oct; 15(10):33-6. PubMed ID: 10249120
[No Abstract] [Full Text] [Related]
14. Pharmaceutical reimbursement: an overview.
Johnson PE
Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S4-10. PubMed ID: 18192246
[TBL] [Abstract][Full Text] [Related]
15. Getting paid for cognitive services.
Meade V
Am Pharm; 1994 Jun; NS34(6):32-6. PubMed ID: 8059683
[No Abstract] [Full Text] [Related]
16. Pharmacy benefit managers and compounding pharmacists: billing for services.
Lees DJ
Int J Pharm Compd; 2014; 18(1):87. PubMed ID: 24881346
[No Abstract] [Full Text] [Related]
17. Hospital reimbursement and clinical pharmacy programs.
Hoffmann RP
Hosp Pharm; 1979 Dec; 14(12):723, 726-7. PubMed ID: 10244960
[No Abstract] [Full Text] [Related]
18. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
[No Abstract] [Full Text] [Related]
19. Part D outdoes expectations. But providers may face more cuts in reimbursement.
DoBias M
Mod Healthc; 2006 Jul; 36(28):8-9. PubMed ID: 16898553
[No Abstract] [Full Text] [Related]
20. Reimbursement for clinical services provided by pharmacists: what are we doing wrong?
Dole EJ; Murawski MM
Am J Health Syst Pharm; 2007 Jan; 64(1):104-6. PubMed ID: 17189588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
